Your browser doesn't support javascript.
loading
Understanding the Gut-Brain Axis and Its Therapeutic Implications for Neurodegenerative Disorders.
Zheng, Yadong; Bonfili, Laura; Wei, Tao; Eleuteri, Anna Maria.
Afiliação
  • Zheng Y; School of Biosciences and Veterinary Medicine, University of Camerino, 62032 Camerino, MC, Italy.
  • Bonfili L; School of Food and Biological Engineering, Zhengzhou University of Light Industry, Zhengzhou 450002, China.
  • Wei T; School of Biosciences and Veterinary Medicine, University of Camerino, 62032 Camerino, MC, Italy.
  • Eleuteri AM; School of Food and Biological Engineering, Zhengzhou University of Light Industry, Zhengzhou 450002, China.
Nutrients ; 15(21)2023 Oct 31.
Article em En | MEDLINE | ID: mdl-37960284
The gut-brain axis (GBA) is a complex bidirectional communication network connecting the gut and brain. It involves neural, immune, and endocrine communication pathways between the gastrointestinal (GI) tract and the central nervous system (CNS). Perturbations of the GBA have been reported in many neurodegenerative disorders (NDDs), such as Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS), among others, suggesting a possible role in disease pathogenesis. The gut microbiota is a pivotal component of the GBA, and alterations in its composition, known as gut dysbiosis, have been associated with GBA dysfunction and neurodegeneration. The gut microbiota might influence the homeostasis of the CNS by modulating the immune system and, more directly, regulating the production of molecules and metabolites that influence the nervous and endocrine systems, making it a potential therapeutic target. Preclinical trials manipulating microbial composition through dietary intervention, probiotic and prebiotic supplementation, and fecal microbial transplantation (FMT) have provided promising outcomes. However, its clear mechanism is not well understood, and the results are not always consistent. Here, we provide an overview of the major components and communication pathways of the GBA, as well as therapeutic approaches targeting the GBA to ameliorate NDDs.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Doenças Neurodegenerativas / Doença de Alzheimer / Microbioma Gastrointestinal Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Doenças Neurodegenerativas / Doença de Alzheimer / Microbioma Gastrointestinal Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article